CYTOSTACK PRIVATE LIMITED

In their own words

CytoStack Private Limited is a physician-led technology startup building AI-powered examination preparation platforms for high-stakes medical and nursing licensing examinations. The company addresses a critical gap in the market: the lack of clinically accurate, adaptive, and exam-specific preparation tools for Indian and Gulf-bound healthcare professionals. Our proprietary platform, PrepEngine, combines three integrated innovation layers: (1) Clinician-validated question intelligence with over 10,000 MCQs reviewed by specialist physicians, (2) AI-powered adaptive learning that builds individual readiness profiles and distinguishes knowledge gaps from time-management issues, and (3) Closed-loop population intelligence that uses aggregate user data to continuously improve content prioritization. We currently operate two live, revenue-generating platforms — PrepMCQ (for Gulf licensing exams: SMLE, DHA, HAAD, OMSB) and PrepCMS (for UPSC Combined Medical Services). Both deliver AI-assisted progress analysis and clinician-validated explanations. A third platform, PrepNCLEX, is under development with a B2B-first launch planned for Kerala nursing institutes. CytoStack is fully bootstrapped, with ₹3,20,000+ in cumulative revenue generated against a minimal monthly burn. The platform is designed for high scalability, with near-zero marginal cost per additional user. We plan to create 5+ direct full-time positions within 12 months and build a network of 30+ commissioned clinical content reviewers as we expand into NCLEX-RN, NEET-PG, and other verticals.

Written by the company on its public Startup India profile. Not verified by us.